Oscar Health, Inc.

1. 01

   Set a 52-week high on 4 Nov 2026

   Closed at $35.19 on 4 Nov 2026: 2.7% below the 52-week high of $36.16 (4 Nov 2026) and 229.2% above the low of $10.69 (30 Mar 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +8.8% (SPY −1.6%, XLV +13.5%). 3 months: +16.9% (SPY −0.4%, XLV +15.5%). 1 year: +105.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: OSCR, SPY and XLV · as of 4 Nov 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $35.19 was 10.7% above its 50-day average ($31.79) and 47.6% above its 200-day average ($23.84). It has closed above the 200-day for 139 sessions, since 20 Apr 2026. The 50-day average crossed above the 200-day on 21 May 2026, 115 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   Volume 2.9× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 13.5M shares was 2.9× the average of the 30 sessions before it (4.6M), as the price rose 8.6%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

5. 05

   Short interest at 6.7% of shares outstanding

   18.3M shares were sold short at the 15 Oct 2026 settlement, 6.7% of the 273.5M shares outstanding; covering them would take 3.7 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close